Search results
Many people quit new weight-loss drugs because of costs, side effects
UPI· 1 day agoReasons for quitting Wegovy, Ozempic or similar drugs may include cost or gastrointestinal side...
Zyn Nicotine Pouches Gaining Popularity as TikTok’s Latest Weight Loss Trend O-Zyn-Pic
Healthline via AOL· 2 days agoNicotine pouches are gaining popularity on social media as a cheap alternative to weight loss drugs,...
New study focuses on what happens if you stay on weight loss drug Wegovy for years
Good Morning America via Yahoo News· 5 days agoAmid the growing popularity of drugs used for weight loss like Ozempic, Wegovy, Mounjaro and...
Hims & Hers rolls out weight-loss shots much cheaper than Ozempic, Wegovy
Fox Business via AOL· 4 days agoHealth and wellness company Hims & Hers announced Monday that it is introducing injectable weight-...
Nestle Enters the Weight-Loss Game With Food for Ozempic Users. What to Know.
InvestorPlace· 3 days agoNestle (OTCMKTS:NSRGY) is getting into the weight-loss business with new packs of frozen food...
4 expert tips for kickstarting your weight loss journey
The Week· 1 day agoThe weight loss journey can be hard enough without all of the conflicting information and trends out...
Scott Disick's Weight Loss Drugs Caught on 'Kardashians' Camera
TMZ· 1 day agoScott Disick's subtly confirming his use of weight loss drugs to achieve his drastic physical...
Nestlé launches food line targeting Ozempic, other weight-loss drug users
NY Post via Yahoo Finance· 3 days agoNestlé is launching a line of food products tailored to people using weight-loss medication in an...
Prescriptions for weight loss, diabetes drugs for young people leaped 600% since 2020, study says
CNN.com· 1 day agoThe number of young people in the US who are prescribed GLP-1 agonist drugs like Wegovy and Ozempic...
There’s yet another amazing use for drugs like Ozempic, study finds
The Independent via Yahoo News· 12 hours agoWhile not officially licensed as a weight loss treatment, drugs such as Ozempic and Wegovy have been...